[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI20149B - Pharmaceutical compositions of tizoxanide and nitazoxanide - Google Patents

Pharmaceutical compositions of tizoxanide and nitazoxanide Download PDF

Info

Publication number
SI20149B
SI20149B SI9820037A SI9820037A SI20149B SI 20149 B SI20149 B SI 20149B SI 9820037 A SI9820037 A SI 9820037A SI 9820037 A SI9820037 A SI 9820037A SI 20149 B SI20149 B SI 20149B
Authority
SI
Slovenia
Prior art keywords
active ingredient
composition according
particle size
pharmaceutical composition
formula
Prior art date
Application number
SI9820037A
Other languages
English (en)
Slovenian (sl)
Other versions
SI20149A (sl
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Lab Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI20149(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Application filed by Romark Lab Lc filed Critical Romark Lab Lc
Publication of SI20149A publication Critical patent/SI20149A/sl
Publication of SI20149B publication Critical patent/SI20149B/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9820037A 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide SI20149B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Publications (2)

Publication Number Publication Date
SI20149A SI20149A (sl) 2000-08-31
SI20149B true SI20149B (en) 2001-08-31

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9820037A SI20149B (en) 1997-05-07 1998-05-06 Pharmaceutical compositions of tizoxanide and nitazoxanide

Country Status (35)

Country Link
EP (2) EP1005342B1 (uk)
JP (1) JP3739802B2 (uk)
KR (2) KR100576646B1 (uk)
CN (2) CN100515420C (uk)
AP (1) AP1103A (uk)
AR (1) AR057242A2 (uk)
AT (2) ATE281166T1 (uk)
AU (1) AU740022B2 (uk)
BG (2) BG109365A (uk)
BR (1) BR9808722A (uk)
CA (2) CA2418634C (uk)
CZ (2) CZ298270B6 (uk)
DE (2) DE69827417T2 (uk)
DK (2) DK1222921T3 (uk)
EA (2) EA002920B1 (uk)
EE (1) EE04870B1 (uk)
ES (2) ES2232687T3 (uk)
GE (1) GEP20032970B (uk)
HK (1) HK1025907A1 (uk)
HU (1) HU229641B1 (uk)
IL (2) IL155799A (uk)
IS (1) IS2087B (uk)
LV (1) LV12492B (uk)
ME (1) ME00530B (uk)
NO (2) NO313983B1 (uk)
NZ (2) NZ513881A (uk)
OA (1) OA11169A (uk)
PL (1) PL193275B1 (uk)
PT (2) PT1005342E (uk)
RO (1) RO120605B1 (uk)
SI (1) SI20149B (uk)
SK (2) SK283946B6 (uk)
TR (1) TR199902733T2 (uk)
UA (2) UA57079C2 (uk)
WO (1) WO1998050035A1 (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EA015560B1 (ru) * 2006-01-09 2011-08-30 Ромарк Лэборетериз, Эл.Си. Способ лечения вирусного гепатита
CN107260695A (zh) * 2009-02-13 2017-10-20 罗马克实验室有限公司 硝唑尼特的控制释放药物剂型
US8846727B2 (en) 2009-05-12 2014-09-30 Romark Laboratories, L.C. Haloalkyl heteroaryl benzamide compounds
CN108042535A (zh) 2009-06-26 2018-05-18 罗马克实验室有限公司 用于治疗流感的化合物和方法
WO2013110975A1 (es) 2012-01-27 2013-08-01 Siegfried Rhein S.A. De C.V. Composición de nitazoxanida mejorada y proceso para prepararla
KR20170081228A (ko) * 2014-11-11 2017-07-11 로마크 레버러토리즈, 엘.씨. 티족사나이드, 그의 유사체 또는 염의 전구 약물을 이용한 치료 조성물 및 방법
KR20200121816A (ko) 2018-02-02 2020-10-26 리플 테라퓨틱스 코포레이션 스테로이드 이량체를 포함하는 유리 제제 및 이의 용도
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
WO2022130406A1 (en) * 2020-12-15 2022-06-23 Cipla Limited Inhalation composition of nitazoxanide or its derivatives for use in coronavirus disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives

Also Published As

Publication number Publication date
SI20149A (sl) 2000-08-31
ES2150404T1 (es) 2000-12-01
EA002908B1 (ru) 2002-10-31
NO20021832D0 (no) 2002-04-18
EP1005342A4 (en) 2001-02-07
CA2418634A1 (en) 1998-11-12
EE9900578A (et) 2000-08-15
AP9901675A0 (en) 1999-12-31
CA2418634C (en) 2004-10-26
DE69809928T2 (de) 2003-04-24
UA57079C2 (uk) 2003-06-16
KR100576646B1 (ko) 2006-05-08
LV12492A (en) 2000-06-20
BR9808722A (pt) 2000-07-11
BG103958A (en) 2000-07-31
HUP0003330A3 (en) 2002-10-28
IS5223A (is) 1999-10-19
CN1158074C (zh) 2004-07-21
IL132516A0 (en) 2001-03-19
HK1025907A1 (en) 2000-12-01
UA74388C2 (uk) 2005-12-15
NO995406L (no) 2000-01-04
NZ513881A (en) 2002-10-25
GEP20032970B (en) 2003-05-27
NO995406D0 (no) 1999-11-04
CZ391199A3 (cs) 2000-07-12
NO335781B1 (no) 2015-02-16
TR199902733T2 (xx) 2000-03-21
DK1005342T3 (da) 2003-03-24
ATE281166T1 (de) 2004-11-15
ME00530B (me) 2011-10-10
IL155799A (en) 2004-08-31
CA2288003A1 (en) 1998-11-12
EP1222921B1 (en) 2004-11-03
BG64973B1 (bg) 2006-11-30
SK283947B6 (sk) 2004-05-04
EP1222921A1 (en) 2002-07-17
AP1103A (en) 2002-09-04
CZ298269B6 (cs) 2007-08-08
KR20010020322A (ko) 2001-03-15
ES2150404T3 (es) 2003-07-01
EE04870B1 (et) 2007-08-15
EA002920B1 (ru) 2002-10-31
IS2087B (is) 2006-03-15
IL132516A (en) 2003-12-10
EA200100956A1 (ru) 2002-02-28
JP2001503067A (ja) 2001-03-06
PT1005342E (pt) 2003-02-28
ES2232687T3 (es) 2005-06-01
LV12492B (en) 2001-01-20
KR100426657B1 (ko) 2004-04-13
CN1255060A (zh) 2000-05-31
WO1998050035A1 (en) 1998-11-12
NO20021832L (no) 2000-01-04
CN100515420C (zh) 2009-07-22
OA11169A (en) 2003-04-25
SK283946B6 (sk) 2004-05-04
NO313983B1 (no) 2003-01-13
PT1222921E (pt) 2005-02-28
JP3739802B2 (ja) 2006-01-25
IL155799A0 (en) 2003-12-23
AU7289598A (en) 1998-11-27
ATE228839T1 (de) 2002-12-15
BG109365A (en) 2006-08-31
HUP0003330A2 (hu) 2001-05-28
CN1552322A (zh) 2004-12-08
DE69827417D1 (de) 2004-12-09
EP1005342B1 (en) 2002-12-04
PL336805A1 (en) 2000-07-17
CA2288003C (en) 2003-10-21
SK151199A3 (en) 2000-07-11
HU229641B1 (en) 2014-03-28
AR057242A2 (es) 2007-11-21
NZ500149A (en) 2001-11-30
KR20040004544A (ko) 2004-01-13
DK1222921T3 (da) 2005-03-07
EP1005342A1 (en) 2000-06-07
DE69809928D1 (de) 2003-01-16
PL193275B1 (pl) 2007-01-31
CZ298270B6 (cs) 2007-08-08
DE69827417T2 (de) 2005-10-27
RO120605B1 (ro) 2006-05-30
EA199901012A1 (ru) 2000-08-28
AU740022B2 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
US4665081A (en) Solid nifedipine preparations and a process for preparing same
US10028953B2 (en) Pharmaceutical composition of rosuvastatin calcium
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
SI20149B (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
HUT75150A (en) Controlled release pharmaceutical compositions based on salts of gamma hydroxy-butyric acid
AU2006245564A1 (en) Pharmaceutical formulation of apomorphine for buccal administration
SK281441B6 (sk) Použitie 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzotiazolu
AU776912B2 (en) Directly compressible matrix for controlled release of single daily doses of clarithromycin
SK4032000A3 (en) MEDICAMENT FORMULATION WITH A CONTROLLED RELEASE OF AN ACTIVEì (54) AGENT
DE60042168D1 (de) Chronotherapeutische diltiazem formulierungen und deren verabreichung
JP2007091633A (ja) メキタジン、イブプロフェン及びトラネキサム酸含有医薬組成物
EP1365751A2 (fr) Granules et granules enrobes au gout masque
WO2004028567A1 (ja) 薬物吸収性改善剤
JP2023520845A (ja) ヒドロキシクロロキン及び／又はクロロキンを含む経口送達システム
ES2648338T3 (es) Composiciones farmacéuticas de raltegravir, procedimientos para su preparación para su uso
BG65472B1 (bg) Използване на саредутант и неговите фармацевтичноприемливи соли за приготвяне на лекарствено средство за използване за лечение или профилактика на голямо депресивно разтройство
JP2003171313A (ja) 医薬組成物
DE60035579D1 (de) Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
DK1255535T3 (da) Lægemiddelsammensætning med kontrolleret frisætning indeholdende tramadol-hydrochlorid
EP0522006A1 (en) Compositions comprising cytotoxic agent and permeation enhancers
CA3183290A1 (en) Tablet comprising opicapone
JP2023521563A (ja) ヒドロキシクロロキン及び／又はクロロキンを含む経皮及び／又は局所送達システム
US4391809A (en) Methods for treating psoriasis
JPH0234325B2 (ja) Shishushitsukanchiryoyososeibutsu
EA199900938A1 (ru) Способ приготовления стабильного фармацевтического состава с фиксированной дозировкой из антиинфекционного агента/агентов и микроорганизмов в качестве активных ингредиентов

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20130108